Results 41 to 50 of about 3,974 (218)

Pityriasis rubra pilaris developing after COVID-19

open access: yesTurkderm Turkish Archives of Dermatology and Venereology, 2022
Coronavirus disease-2019 (COVID-19) has been associated with multiple skin lesions as well as causing common respiratory symptoms. We presented a case of pityriasis rubra pilaris that developed after COVID-19 infection and treated with anti-tumor ...
Mine Müjde Kuş   +6 more
doaj   +1 more source

Beneficial effect of ustekinumab in familial pityriasis rubra pilaris with a new missense mutation in CARD14 [PDF]

open access: yes, 2018
Pityriasis rubra pilaris (PRP) represents a group of rare chronic inflammatory skin disorders in which ~1 in 20 affected individuals show autosomal dominant inheritance.
Hsu, C-K   +3 more
core   +1 more source

Pityriasis rubra pilaris – erütrodermia haruldane põhjus. Haigusjuhu kirjeldus [PDF]

open access: yes, 2017
Eütrodermia on äge dermatoloogiline seisund, mille korral esineb nahal generaliseerunud erüteem, mis haarab 85–90% kehapinnast ning millega kaasneb sageli ketendus.
Erm, Triin   +2 more
core   +2 more sources

Pityriasis Rubra Pilaris

open access: yesJournal of the American Academy of Dermatology
Greiling TM, Brown F, Syed HA.
europepmc   +3 more sources

Interleukin 23-Helper T Cell 17 Axis as a Treatment Target for Pityriasis Rubra Pilaris. [PDF]

open access: yes, 2017
Treatment of pityriasis rubra pilaris (PRP) is solely based on its resemblance to psoriasis rather than any knowledge of its pathomechanism. Insight into pathogenic mediators of inflammation is essential for targeted and valid treatment options that ...
Conrad, C.   +8 more
core   +2 more sources

Ustekinumab-Induced Fatal Acute Heart Failure in a Young Female: A Case Report

open access: yesMethodist DeBakey Cardiovascular Journal, 2022
Data regarding short- and long-term cardiovascular complications of biological agents is lacking. Herein, the authors reported a case of abrupt onset of acute heart failure induced by ustekinumab treatment for resistant pityriasis rubra pilaris in a ...
Mahmoud Abdelnabi   +4 more
doaj   +1 more source

Analysis of CARD14 Polymorphisms in Pityriasis Rubra Pilaris: Activation of NF-κB. [PDF]

open access: yes, 2015
Pityriasis rubra pilaris (PRP) is a rare inflammatory papulo-squamous disorder manifesting with palmoplantar keratoderma and follicular hyperkeratotic papules which tend to coalesce into large, scaly, erythematous plaques often progressing to exfoliative
Andrews, Jonathan   +9 more
core   +2 more sources

Systemic sclerosis in a patient with pityriasis rubra pilaris [PDF]

open access: yes, 2011
Pityriasis rubra pilaris (PRP) is a rare, chronic erythematous squamous disorder of unknown etiology. It has been found in association with several autoimmune diseases, including thyroiditis, myositis, myasthenia gravis and vitiligo.
Bahloul, Z   +4 more
core   +2 more sources

Case for diagnosis. Atypical Grover's disease, [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2021
A 55-year-old male presented with an eight-month history of erythematous papules and plaques with demarcated areas of spared skin on his trunk, upper extremities, neck, and face.
Pablo Vargas-Mora   +3 more
doaj   +1 more source

Pityriasis rubra pilaris

open access: yesDer Hautarzt, 2012
Pityriasis rubra pilaris is an inflammatory papulosquamous skin disease of unknown etiology. Incidence rates vary between 1:5,000-1:50,000. Six subtypes are differentiated on clinical background. The juvenile circumscribed subtype has best prognosis. Generalized disease impairs quality of life of patients.
Leger, Marie   +5 more
openaire   +7 more sources

Home - About - Disclaimer - Privacy